When personal factors were considered, BRCA1/2 mutations were observed in 11.6% of early-onset breast cancer patients, 14.9% of bilateral breast cancer patients, and 66.7% of patients who were diagnosed with both breast and ovarian cancer. This evidence concerns the gene BRCA1 and breast carcinoma.